Cargando…
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
Autism spectrum disorders (ASDs) are genetically and clinically heterogeneous and lack effective medications to treat their core symptoms. Studies of syndromic ASDs caused by single gene mutations have provided insights into the pathophysiology of autism. Fragile X and Rett syndromes belong to the s...
Autores principales: | Wang, Hansen, Pati, Sandipan, Pozzo-Miller, Lucas, Doering, Laurie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341567/ https://www.ncbi.nlm.nih.gov/pubmed/25767435 http://dx.doi.org/10.3389/fncel.2015.00055 |
Ejemplares similares
-
Autism spectrum disorders: emerging mechanisms and mechanism-based treatment
por: Wang, Hansen, et al.
Publicado: (2015) -
Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders
por: Telias, Michael
Publicado: (2019) -
Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
por: Bach, Snow, et al.
Publicado: (2021) -
A novel DNA-binding feature of MeCP2 contributes to Rett syndrome
por: Xu, Xin, et al.
Publicado: (2013) -
Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013)